Abstract Details

Title Longitudinal Analysis of Anti-JCV Antibody Index in Natalizumab-Treated Multiple Sclerosis Patients

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 182

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Iain McGurgan (Oriel College) PRESENTER	No disclosure on file
Andrew Lockhart, MD (GlaxoSmithKline)	No disclosure on file
Michael Hutchinson, MD (St Vincent's University Hospital)	Dr. Hutchinson has nothing to disclose.
	No disclosure on file

��ɫ����